Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Shares Bought by Credit Suisse AG

Credit Suisse AG increased its position in Apollo Medical Holdings, Inc. (NASDAQ:AMEH) by 5.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,251 shares of the company’s stock after buying an additional 2,558 shares during the period. Credit Suisse AG owned about 0.09% of Apollo Medical worth $1,869,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Tower Research Capital LLC TRC raised its position in shares of Apollo Medical by 91.2% in the first quarter. Tower Research Capital LLC TRC now owns 1,000 shares of the company’s stock valued at $36,000 after buying an additional 477 shares during the last quarter. FMR LLC raised its position in shares of Apollo Medical by 36.1% in the second quarter. FMR LLC now owns 1,067 shares of the company’s stock valued at $41,000 after buying an additional 283 shares during the last quarter. UBS Group AG acquired a new position in shares of Apollo Medical in the third quarter valued at approximately $52,000. Lazard Asset Management LLC acquired a new position in shares of Apollo Medical in the first quarter valued at approximately $66,000. Finally, Quantbot Technologies LP acquired a new position in shares of Apollo Medical in the second quarter valued at approximately $54,000. Institutional investors and hedge funds own 35.88% of the company’s stock.

Apollo Medical Price Performance

Apollo Medical stock opened at $37.90 on Tuesday. Apollo Medical Holdings, Inc. has a 1 year low of $26.89 and a 1 year high of $44.41. The firm has a 50 day moving average price of $35.46 and a 200 day moving average price of $35.20. The company has a market cap of $2.18 billion, a price-to-earnings ratio of 34.77, a PEG ratio of 2.87 and a beta of 0.83. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.50 and a current ratio of 2.50.

Apollo Medical (NASDAQ:AMEH) last released its earnings results on Monday, August 7th. The company reported $0.28 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.28. Apollo Medical had a net margin of 3.95% and a return on equity of 11.00%. The firm had revenue of $348.21 million during the quarter, compared to the consensus estimate of $341.10 million. Sell-side analysts predict that Apollo Medical Holdings, Inc. will post 1.15 earnings per share for the current year.

Apollo Medical Company Profile

Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.